AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities

AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities

LOS ANGELES--(BUSINESS WIRE)--Apr 27, 2026-

AHF • AHF’s Gilead Shareholder Resolution Seeks Transparency on Drug Patent Exclusivities

With Proposal #6, AIDS group urges shareholders to vote to request the company produce a report on the impact of extended patent exclusivities on patient access to Gilead medications LOS ANGELES (April 27, 2026) – Life-saving drugs are worthless if patients cannot access the medications. At Gilead’s annual general meeting on April 30th, 2026, shareholders have an opportunity to shine a light on the inner workings of the company’s drug developmen…